Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Game-changing FinTech Company You Need to Know About

Back in June , we introduced our Stockhouse investor audience to an emerging FinTech giant and took a deep dive into how this Canadian company is on the forefront of developing artificial intelligence (AI) that transforms data into knowledge. Toronto ON-based Analyti...

Thinking North: Diversification and Trends

On June 20, 2019, I had the pleasure of being the keynote speaker for the eighth time at the Thinking North event. It was sponsored by Stockhouse, First Republic Capital, Ensign Capital Inc., Bantr Inc., DealMaker, FTMIG, CSE and Small Cap Power. The event held in Toronto...

Aurinia Pharma Shares Open 100% Higher on Phase 3 Lupus Data

Shares of Aurinia Pharmaceuticals traded much higher today after it reported positive results from its Phase 3 AURORA trial of Voclosporin for treatment of lupus nephritis. The company plans to submit a New Drug Application to the FDA in H1/20. Yesterday afternoon, Vi...

Exelixis Shares Climb 21% on Positive Phase 3 Advanced Kidney Cancer Study Results

Shares of Exelixis reached a new 52-week high price after the firm reported positive topline results from its Pivotal Phase 3 CheckMate -9ER trial evaluating Opdivo® (nivolumab) in combination with CABOMETYX® (cabozantinib) in previously untreated advanced ...

Connect the Dots: A Speculator’s Paradise is Heating Up

The U.S. Federal Reserve and central banks around the world appear to have the printing presses going full tilt these days. This has fueled the greatest “V recovery” any buy the dip investor could have asked for. Tech stocks and pr...

Sanofi Pays Lexicon Pharma $260 Million to Settle Diabetes Drug Dispute

Lexicon Pharmaceuticals shares traded higher by more than 30% today after the company announced termination of its alliance with Sanofi SA and a $260 million settlement over its diabetes drug Zynquista. Yesterday afternoon, The Woodlands, Tex.-based Lexicon Pharmaceu...

Are We There Yet?

Gold is trading around US$1600/ounce. In my interviews that were done between 2017-2019, I was asked about the prospects of gold. I stated that I believed between 2020-2021 we’d see gold above $2000 + ounce. We are getting closer. This bodes extremely well fo...

Tax loss selling…is it a good time for investors?

Every year on Black Friday, shoppers anticipate great deals and are lined out the door to get a discount on a TV or on a much needed appliance. Buyers will go to many lengths, including camping outside the store to be the first in or even trampling on other shoppers to get t...

PDAC 2020

PDAC 2020 will be taking place during March 1 st -March 4 th at the Toronto Metro Convention Centre. It is the world’s premier mining and finance conference. “ The World’s Premier Mineral Exploration & Mining Convention is the leading convent...

JOIN ME FOR MY TALK AT PDAC 2020

I have the honour of speaking again at PDAC this Sunday March 1st. As you know, it has been a tumultuous week for the overall stock markets including gold stocks. I will be covering that and many other pertinent topics in my talk. I will be speaking at 3:45PM. Following my t...
1 2 3 4 5 6 7 8 9 10 ...